Introduction
Opioid manufacturers, distributors, pharmacies and prescribers
are facing a deluge of lawsuits that involve criminal and civil
claims in both federal and state courts. On May 2, 2019, a federal
jury in Boston, Massachusetts, found John Kapoor, the self-made
billionaire and founder of Insys Pharmaceuticals, along with four
other executives, guilty of RICO conspiracy for their roles in
Insys' scheme to bribe medical practitioners and defraud
Medicare and private insurance carriers.1 The verdict
followed a 10-week trial during which jurors heard testimony
concerning the plan Insys employed to market Subsys, a highly
powerful fentanyl spray.2 Kapoor and his former
colleagues are scheduled to be sentenced in September.3
Each defendant faces to up to 20 years in prison for their
crimes.4